Due to its involvement in many cellular processes such as normal ageing, tumor suppression, chronic diseases and many more, cellular senescence has gained increasing attention since its first description over 50 years ago. In addition, understanding of cellular senescence is invaluable in the development of therapeutic targets in the fight against age-related co-morbidities, cancer and chronic disease progression.

Over-expressed in senescent cells, Senescence-associated β-galactosidase (SA-β-gal), has been widely used as a marker of cellular senescence. In order to specifically detect this biomarker directly in living cells or tissues, let’s take a look at an easy and ready-to-use assay recently developed: the SPiDER-βGal- Cellular Senescence Detection kit.

PBL Assay Science, the specialists of Interferon related quality reagents, have just released 4 new unique products to be used in neutralization assays. I am pleased to introduce them in this post, in which you’ll discover examples of titration data, as well as reactivity and cross-reactivity information.

PBL assay specializes in the development of IFN related research Tools. One of their most appreciated assay kit by the IFN research community is the ELISA test kit for all Human IFN Alpha subtypes (41115).

Its unique features such as high sensitivity, matrix compatibility and broad detection of IFN alpha subtypes explain this popularity.

RayBiotech has just announced the release of a new ELISA test technology breakthrough that I am quite thrilled to share with you. If you have precious samples with low abundant target and which require high sensitivity, then this post will be of interest to you!

The RayBio® Immuno-Quantitative ELISA (IQELISA) kit is an innovative assay platform that combines the specificity and ease of use of a sandwich ELISA test with the sensitivity of real-time PCR. This results in an assay that is cutting edge and yet familiar, enabling the use of only 1/10th of the typical sample volume while providing up to 10x more sensitivity than a traditional ELISA test. The IQELISA technology is completely novel, patent pending, and has no equivalent in the market at this time.